Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 19 Apr 2007 |
| Genmab Initiates HuMax-EGFr Combination Study in Non Small Cell Lung Cancer | 12 Apr 2007 |
| Genmab's 2006 Annual Report | 29 Mar 2007 |
| Genmab A/S Summons Annual General Meeting | 29 Mar 2007 |
| Genmab to Present at Lehman Brothers Tenth Annual Global Healthcare Conference | 19 Mar 2007 |